FDA Inspection 986030 — USC Reproductive Endocrinology and Infertility
The FDA completed an inspection of USC Reproductive Endocrinology and Infertility on June 15, 2016 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Los Angeles, CA (United States)